Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial sulfur- and nitrogen-containing proteins and enzymes constitute a diverse group of essential bacterial components that serve as the primary targets for silver-based antimicrobials and other heavy metal-containing antiseptics. These targets include a wide array of enzymes involved in the respiratory chain and central metabolism, as well as structural proteins, which contain reactive functional groups such as thiols (from cysteine) and amines (from lysine or histidine). Silver ions (Ag+) exert their antibacterial effect by binding to these sulfur and nitrogen atoms, causing structural distortion, protein denaturation, and the loss of enzymatic function (Lansdown, 2006). This multi-site interaction disrupts the bacterial cell wall, inhibits DNA replication, and halts cellular respiration, leading to rapid cell death (Jung et al., 2008). Due to the non-specific nature of this interaction across many vital proteins, these targets are effective against a broad spectrum of Gram-positive and Gram-negative bacteria. Clinically, agents targeting these proteins are primarily used in topical applications, such as silver sulfadiazine for burn wounds, to prevent and treat localized infections (Slawson et al., 1992). Because the mechanism involves simultaneous damage to numerous essential proteins, the development of high-level bacterial resistance is significantly more complex than with single-target antibiotics.
Silver ions and other heavy metal cations bind to the sulfhydryl (thiol) and amino groups of bacterial proteins and enzymes, leading to protein denaturation, inhibition of enzymatic activity, and disruption of the bacterial cell membrane and respiratory chain.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial sulfur- and nitrogen-containing proteins and enzymes.